Fig. 2: The level of miR663AHG expression in colon cancer tissue samples from patients with various clinicopathological characteristics. | Cell Death Discovery

Fig. 2: The level of miR663AHG expression in colon cancer tissue samples from patients with various clinicopathological characteristics.

From: LncRNA miR663AHG represses the development of colon cancer in a miR663a-dependent manner

Fig. 2: The level of miR663AHG expression in colon cancer tissue samples from patients with various clinicopathological characteristics.

A The level of miR663AHG expression in colon cancer (CC) and paired surgical margin (SM) samples from 119 patients, as measured by qRT-PCR. The P-value in the Mann–Whitney U test and the ratio of CCs with miR663AHG downregulation are labeled. B Comparisons of the level of miR663AHG expression in CCs at different pTNM stages, lymph metastasis, and differentiation states. Detailed information is listed in Table S1. C Overall survival curves for patients with colon cancer with high and low miR663AHG expression (according to the median value). D The coexpression status of miR663AHG and miR663a in 182 (CC and SM) tissue samples. E The coexpression status of miR663AHG and miR663a in 353 ovarian cancer tissue samples. The Spearman correlation coefficient (r) is labeled.

Back to article page